How and when to refer patients for oncogenetic counseling in the era of PARP inhibitors

Poly(ADP-ribose)polymerase (PARP) inhibitors are targeted therapy for cancers with homologous repair deficiency (HRD). They were first approved for ovarian cancer and have changed current treatment strategies. They have also demonstrated efficacy in HER2-negative metastatic breast cancer and advance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Neviere, Zoé, De La Motte Rouge, Thibault, Floquet, Anne, Johnson, Alison, Berthet, Pascaline, Joly, Florence
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052467/
https://ncbi.nlm.nih.gov/pubmed/32165926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919897530
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados